Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group Polysomnography Study to Assess the Efficacy and Safety of a 16-day Oral Administration of ACT-078573 in Adult Subjects With Chronic Primary Insomnia
Multi-center, Double-blind, Randomized, Placebo-controlled, Active Reference, Parallel-group Polysomnography Study to Assess the Efficacy and Safety of a 16-day Oral Administration of ACT-078573 in Adult Subjects With Chronic Primary Insomnia
A polysomnography study to evaluate the effect, safety and tolerability of oral administration of almorexant (ACT 078573) in adult subjects with primary insomnia.
Inclusion Criteria:
Exclusion Criteria:
Heidelburg, Victoria 3084, Australia
Montigny Le Tilleuil, Belgium
Katerinska, Czechia
Ostava-Poruba, Czechia
Berlin, Germany
Freiburg im Breisgau, Germany
Marburg, Germany
Bologna, IT-27100, Italy
Pisa, IT-56126, Italy
Basel, CH-4025, Switzerland
Chêne-Bourg, CH-1225, Switzerland
Zurich, CH-8091, Switzerland
Kiev, Ukraine